Stephen Pawsey
Geen lopende functies
Loopbaan van Stephen Pawsey
Eerdere bekende functies van Stephen Pawsey
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| NIOX GROUP PLC | Hoofd Techniek/Wetenschap/O&O | 01-01-2014 | - |
| Pharmagene Plc | Hoofd Techniek/Wetenschap/O&O | - | - |
| Corporate Officer/Principal | - | 11-04-2011 | |
Circassia Ltd.
 Circassia Ltd. Pharmaceuticals: OtherHealth Technology Circassia Ltd. develops medicines for allergic and auto-immune diseases. The company was founded by Anthony Barrington Kay and Mark Larché on December 29, 1998 and is headquartered in Oxford, the United Kingdom. | Hoofd Techniek/Wetenschap/O&O | 01-01-2014 | - |
| VERNALIS | Corporate Officer/Principal | 22-11-2010 | - |
Opleiding van Stephen Pawsey
| University of London | Doctorate Degree |
Statistieken
Internationaal
| Verenigd Koninkrijk | 6 |
Operationeel
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 2 |
| Health Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| NIOX GROUP PLC | Health Services |
| Bedrijven in privébezit | 3 |
|---|---|
Ligand UK Ltd.
 Ligand UK Ltd. Pharmaceuticals: MajorHealth Technology Ligand UK Ltd. is a commercial stage pharmaceutical company. Its products include Tuzistra XR, targeting the U.S. prescription cough-cold market, Moxatag, a once-a-day formulation of the antibiotic and amoxicillin, and frovatriptan, used for the acute treatment of migraine. It also develops and commercializes multiple novel products focused on the U.S. prescription cough-cold market. The company was founded by Keith G. McCullagh and Andre L. Lamotte in 1988 and is headquartered in Winnersh, the United Kingdom. | Health Technology |
| Pharmagene Plc | Health Technology |
Circassia Ltd.
Circassia Ltd. Pharmaceuticals: OtherHealth Technology Circassia Ltd. develops medicines for allergic and auto-immune diseases. The company was founded by Anthony Barrington Kay and Mark Larché on December 29, 1998 and is headquartered in Oxford, the United Kingdom. | Health Technology |
- Beurs
- Insiders
- Stephen Pawsey
- Ervaring
